Public information presented according to the provisions of Directive 2001/18/EC
File:
Trial reference:
Phase I/II study to evaluate the safety and effects on Progranulin levels of PR006 in patients with Fronto-Temporal Dementia with Progranulin mutations (FTD-GRN).
Doc type: